Literature DB >> 23999567

Clinical reasoning: a 40-year-old man with CIDP-like illness resistant to treatment.

Rajat Lahoria1, Chafic Karam, Angela Dispenzieri, P James B Dyck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23999567      PMCID： PMC3885213          DOI： 10.1212/WNL.0b013e3182a3523b

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Vascular endothelial growth factor and POEMS.

Authors:  Peter J Dyck; JaNean Engelstad; Angela Dispenzieri
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

2.  Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.

Authors:  D Cocito; S Grimaldi; I Paolasso; Y Falcone; G Antonini; L Benedetti; C Briani; R Fazio; S Jann; S Matà; M Sabatelli; E Nobile-Orazio
Journal:  Eur J Neurol       Date:  2011-08-05       Impact factor: 6.089

3.  Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.

Authors:  Michelle L Mauermann; Eric J Sorenson; Angela Dispenzieri; Jay Mandrekar; Guillermo A Suarez; Peter J Dyck; P James B Dyck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-06       Impact factor: 10.154

Review 4.  POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

5.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

Review 6.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

7.  Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.

Authors:  Kazuaki Kanai; Setsu Sawai; Kazuyuki Sogawa; Masahiro Mori; Sonoko Misawa; Kazumoto Shibuya; Sagiri Isose; Yumi Fujimaki; Yuichi Noto; Yukari Sekiguchi; Saiko Nasu; Chiaki Nakaseko; Shigetsugu Takano; Hideyuki Yoshitomi; Masaru Miyazaki; Fumio Nomura; Satoshi Kuwabara
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 8.  Review of peripheral neuropathy in plasma cell disorders.

Authors:  Jeannine Silberman; Sagar Lonial
Journal:  Hematol Oncol       Date:  2008-06       Impact factor: 5.271
  8 in total
  1 in total

1.  CIDP mimics: a case series.

Authors:  Orly Moshe-Lilie; Erik Ensrud; Thomas Ragole; Chahin Nizar; Diana Dimitrova; Chafic Karam
Journal:  BMC Neurol       Date:  2021-02-28       Impact factor: 2.474
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.